MY200429A - Therapeutic agent for aspiration pneumonia, lung suppuration, or lung abscess - Google Patents

Therapeutic agent for aspiration pneumonia, lung suppuration, or lung abscess

Info

Publication number
MY200429A
MY200429A MYPI2019007111A MYPI2019007111A MY200429A MY 200429 A MY200429 A MY 200429A MY PI2019007111 A MYPI2019007111 A MY PI2019007111A MY PI2019007111 A MYPI2019007111 A MY PI2019007111A MY 200429 A MY200429 A MY 200429A
Authority
MY
Malaysia
Prior art keywords
lung
therapeutic agent
suppuration
aspiration pneumonia
abscess
Prior art date
Application number
MYPI2019007111A
Inventor
Masaaki Odajima
Sayoko Tanioka
Takaaki Sunouchi
Asako Tabuchi
Original Assignee
Kyorin Seiyaku Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Seiyaku Kk filed Critical Kyorin Seiyaku Kk
Publication of MY200429A publication Critical patent/MY200429A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

[Problem] The present invention pertains to a safer and more efficient therapeutic agent for respiratory tract infections. [Solution] A therapeutic agent for aspiration pneumonia, lung suppuration, or lung abscess, the agent containing as an active ingredient 7-[(3S,4S)-3-{(cyclopropylamino)methyl}-4-fluoropyrrolidin-1-yl]-6-fluoro-1-(2-fluoroethyl)-8-methoxy-4-oxo-1,4-15 dihydroquinoline-3-carboxylic acid or a pharmaceutically acceptable salt thereof.
MYPI2019007111A 2017-06-16 2018-06-15 Therapeutic agent for aspiration pneumonia, lung suppuration, or lung abscess MY200429A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762520961P 2017-06-16 2017-06-16
JP2018068159 2018-03-30
PCT/JP2018/022846 WO2018230686A1 (en) 2017-06-16 2018-06-15 Therapeutic agent for aspiration pneumonia, lung suppuration, or lung abscess

Publications (1)

Publication Number Publication Date
MY200429A true MY200429A (en) 2023-12-26

Family

ID=64660738

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2019007111A MY200429A (en) 2017-06-16 2018-06-15 Therapeutic agent for aspiration pneumonia, lung suppuration, or lung abscess

Country Status (6)

Country Link
KR (1) KR20240096794A (en)
CN (3) CN121197162A (en)
EA (1) EA202090066A1 (en)
MY (1) MY200429A (en)
TW (1) TW202415375A (en)
WO (1) WO2018230686A1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4468701B2 (en) * 2002-03-18 2010-05-26 杏林製薬株式会社 10- (3-Cyclopropylaminomethyl-1-pyrrolidinyl) pyridobenzoxazine carboxylic acid derivative effective against resistant bacteria
SG144936A1 (en) 2003-09-10 2008-08-28 Kyorin Seiyaku Kk 7-(4-substituted-3-cyclopropylaminomethyl-1- pyrrolidinyl)quinolonecarboxylic acid derivative
SA112330992B1 (en) 2011-11-10 2015-09-13 كيورين فارماسوتيكال كو.، ليمتد Crystalline form of the 7-{(3S,4S)-3 [(cyclopropylamino)methyl]-4- fluoropyrrolidine-1-YL}-6-fluoro-1-(2-fluoroethyl)-8-methoxy-4-OXO- 1,4-dihydroquinoline-3-carboxylic acid
BR112017019205A2 (en) * 2015-03-13 2018-04-24 Kyorin Pharmaceutical Co., Ltd. Respiratory-tract-infection medical treatment agent
EP3305294A4 (en) 2015-06-02 2019-02-20 Kyorin Pharmaceutical Co., Ltd. AQUEOUS MEDICINE

Also Published As

Publication number Publication date
TW202415375A (en) 2024-04-16
KR20240096794A (en) 2024-06-26
EA202090066A1 (en) 2020-04-15
CN121466090A (en) 2026-02-06
CN121197162A (en) 2025-12-26
CN116549446A (en) 2023-08-08
WO2018230686A1 (en) 2018-12-20

Similar Documents

Publication Publication Date Title
PH12020551089A1 (en) Pyrrolopyrimidine compounds used as tlr7 agonist
ZA202002139B (en) Combination pharmaceutical agents as rsv inhibitors
PH12018502747A1 (en) Boronic acid derivatives and therapeutic uses thereof
MX2015010971A (en) Novel pyrazole derivative.
EP4309735A3 (en) Pharmaceutical composition of s-ketamine hydrochloride
NZ631100A (en) Soft chewable pharmaceutical products
PH12015502013B1 (en) Pharmaceutical composition of s-ketamine hydrochloride
MX394588B (en) PHARMACEUTICAL COMPOSITION.
EP2871187A4 (en) NOVEL COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AS ACTIVE INGREDIENT
PH12017501505B1 (en) Respiratory infection treating agent
UA117751C2 (en) Tylosin derivatives and method for preparation thereof
EP3404020A4 (en) PYRIDINOL DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AS AN ACTIVE INGREDIENT
PH12019502835A1 (en) Therapeutic agent for aspiration pneumonia, lung suppuration, or lung abscess
EA202090066A1 (en) THERAPEUTIC FOR THE TREATMENT OF ASPIRATED PNEUMONIA, PULMONARY FORCING OR LUNG ABCESS
EA201890789A1 (en) CONTAINING ZINEOL COMPOSITION FOR THE TREATMENT OF NOSE DISEASES
WO2011095768A8 (en) Lantibiotic salts
WO2016092560A3 (en) Dual release bilayer tablets comprising metformin
RU2726625C2 (en) Pharmaceutical composition comprising a polypeptide
PE20210927A1 (en) ANTIMICROBIAL COMPOSITIONS WITH EFFERVESCENT AGENTS
TH1901007819A (en) Antibiotics for aspiration pneumonia, lung abscesses, or pus formation in the lungs.
WO2018084817A3 (en) A new form of active agent
GB2571235A (en) Antimicrobial formulations for the improved treatment of veterinary hoof infections
EA201300956A1 (en) PHARMACEUTICAL COMPOSITION
UA88315U (en) Antibacterial composition
UA114828C2 (en) APPLICATION OF DECAMETOXIN AS A PHARMACEUTICAL ACTIVE SUBSTANCE FOR TREATMENT OF Gastrointestinal and Intestinal Infections Oral